- Total Payouts: $66,783,095
- Average Payout: $4,884
- Payouts per Capita: $9,500
Massachusetts ranks 4th in per capita payouts, with nearly $67 million in total and an average payout of $4,884. Known for its prestigious medical and research institutions, Massachusetts attracts significant pharmaceutical investment. The high payouts per capita reflect the state’s critical role in medical innovation and influence, making it a strategic area for pharmaceutical engagement with healthcare providers.
- Total Payouts: $68,555,063
- Average Payout: $5,400
- Payouts per Capita: $9,920
Tennessee is notable for its 2nd-place ranking in per capita pharmaceutical payouts, with a substantial average payout of $5,400 and total payouts of over $68 million. This high ranking indicates concentrated pharmaceutical influence, likely reflecting Tennessee’s robust medical sector and an emphasis on provider relationships within the state. Pharmaceutical companies’ strong focus here underscores Tennessee’s role in the healthcare landscape.
- Total Payouts: $80,410,344.80
- Avg. Payout Amount: $4,310.62
- Total Payouts per Capita: $7,702.59
North Carolina, ranking 12th per capita, received over $80 million from pharmaceutical companies. The state’s average payout of $4,310 suggests substantial individual payments, reflecting the importance of North Carolina’s healthcare providers to pharmaceutical firms. This higher-than-average payout amount could point to a targeted strategy within the state’s medical community.
- Total Payouts: $87,804,881.43
- Avg. Payout Amount: $3,568.58
- Total Payouts per Capita: $7,441.44
Ohio ranks 15th in per capita payouts, with over $87 million in payments from pharmaceutical companies. With an average payout of $3,568, Ohio’s numbers indicate widespread pharmaceutical engagement, though the payouts per capita are somewhat lower than in the top states. Ohio’s size and healthcare network contribute to its mid-level ranking in this category.
- Total Payouts: $104,042,524.76
- Avg. Payout Amount: $3,593.62
- Total Payouts per Capita: $8,001.61
Pennsylvania ranks 8th in per capita payouts, with total payments surpassing $104 million. The state’s average payout is $3,593, suggesting a steady distribution of funds across medical providers. Pennsylvania’s significant healthcare industry and large population make it a prime focus for pharmaceutical companies, as evidenced by its higher-than-average payouts per capita.
- Total Payouts: $117,668,726
- Average Payout: $4,518
- Payouts per Capita: $9,184
Illinois ranks 5th for pharmaceutical payouts per capita, with over $117 million in total payouts. Each payout averages around $4,518, indicating relatively high individual payments. Illinois’s high ranking reflects its significant healthcare infrastructure, especially in urban centers like Chicago, making it a critical area for pharmaceutical companies aiming to influence a broad spectrum of providers.
- Total Payouts: $168,581,494.23
- Avg. Payout Amount: $3,443.81
- Total Payouts per Capita: $7,827.10
Florida ranks 10th in per capita pharmaceutical payouts, with a total of over $168 million. The average payout per transaction is $3,443, reflecting frequent but smaller transactions across the state. Known for its large retiree population, Florida’s medical providers receive considerable attention from pharmaceutical companies, likely due to high demand for healthcare services.
- Total Payouts: $178,766,516.96
- Avg. Payout Amount: $4,092.83
- Total Payouts per Capita: $8,849.28
New York, ranking 6th in per capita payouts, sees a significant influx from pharmaceutical companies, totaling nearly $179 million. The average payout is $4,092, suggesting steady, moderately sized payments across the state. With a substantial healthcare sector and diverse medical landscape, New York’s high rank reflects its critical role for pharmaceutical firms engaging with providers in this densely populated state.
- Total Payouts: $192,967,324.57
- Avg. Payout Amount: $3,623.80
- Total Payouts per Capita: $6,620.83
Texas ranks 19th in pharmaceutical payouts per capita, with a total of nearly $193 million in payments to healthcare providers. The state’s average payout of $3,623 is moderate compared to others, indicating a widespread but less concentrated flow of funds. Texas’ large population and the medical industry's influence make it a strategic target for pharmaceutical outreach, though payments per capita are lower than some smaller states.
- Total Payouts: $307,026,538.66
- Avg. Payout Amount: $4,552.05
- Total Payouts per Capita: $7,765.31
California, the largest state by population, ranks 11th in terms of pharmaceutical payouts per capita. With total payouts exceeding $307 million, California leads in overall spending. Each payout averages $4,552, slightly above the national average. While per capita payouts are not the highest, they are still substantial given California’s large population, highlighting the state’s importance to pharmaceutical companies aiming to influence the medical field.
